Newsbenzinga
AstraZeneca Announces Tozorakimab Demonstrates Reduction In Participants With Chronic Obstructive Pulmonary Disease In Phase III OBERON, TITANIA Studies
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…